
- Get in Touch with Us
Last Updated: Apr 25, 2025 | Study Period: 2024-2030
Ultra wide field imaging (UWFI) and wide field imaging (WFI) are becoming more and more well-liked. WFI stands for imaging with a field of view more than 50 degrees. UWFI devices can image up to 200 degrees. They can successfully image more than 80% of the retinal surface area.
With the use of ultra-wide field imaging, we may examine the retinal peripheral more closely. It makes it easier to evaluate fundus colour photographs as well as fluorescein, indocyanine green, fundus autofluorescence, and red and green free images.
Finding vascular lesions using UWF FA has been demonstrated to be more successful than using traditional FA. In 10% of diabetic eyes, disease was found that was not visible with conventional FA, such as retinal nonperfused regions and retinal neovascularization.
A single image capture that has vortex ampullae in each of the four quadrants is referred to be a UWF image. 11. UWF's potential to enhance retinal disease screening and detection has been backed up by hundreds of peer-reviewed, published clinical trials.
Your doctor can now discover symptoms of eye diseases that were previously undetectable thanks to retinal imaging. Retinal imaging can be used to identify eye disorders such diabetic retinopathy, glaucoma, age-related macular degeneration, and detached retina.
All of these eye conditions require prompt medical attention to avoid vision loss.
The Global Ultra-wide field retinal imaging device market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
Ultra-Widefield Retinal Imaging Device Unveiled by Optos
The US introduction of Monaco, the first ultra-widefield (UWF) imaging equipment coupled with Optical Coherence Tomography, has been announced by Optos plc, a medical retinal imaging firm. The Nikon Corporation owns Optos.
The Monaco device, a new desk-top small UWF retinal imaging equipment, increases imaging capability and diversifies the company's offering for the ophthalmic sectors. With ultra-widefield colour imaging, 3-in-1 colour depth imaging, and autofluorescence (AF) modalities integrated with OCT, Monaco is the company's first combined imaging equipment.
It has been demonstrated that a thorough examination that includes OCT, which provides details on the structure and function of the retina, and ultra-widefield imaging improves pathology diagnosis, disease treatment, and clinic throughput.
The ultra-widefield retinal imaging system now includes OCT, giving eye care professionals a more complete set of imaging techniques in a single device that will help them identify and treat retinal disease earlier and more successfully.
Sl no | Topic |
1 | Market Segmentation |
2 | Scope of the report |
3 | Abbreviations |
4 | Research Methodology |
5 | Executive Summary |
6 | Introduction |
7 | Insights from Industry stakeholders |
8 | Cost breakdown of Product by sub-components and average profit margin |
9 | Disruptive innovation in the Industry |
10 | Technology trends in the Industry |
11 | Consumer trends in the industry |
12 | Recent Production Milestones |
13 | Component Manufacturing in US, EU and China |
14 | COVID-19 impact on overall market |
15 | COVID-19 impact on Production of components |
16 | COVID-19 impact on Point of sale |
17 | Market Segmentation, Dynamics and Forecast by Geography, 2024-2030 |
18 | Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030 |
19 | Market Segmentation, Dynamics and Forecast by Application, 2024-2030 |
20 | Market Segmentation, Dynamics and Forecast by End use, 2024-2030 |
21 | Product installation rate by OEM, 2023 |
22 | Incline/Decline in Average B-2-B selling price in past 5 years |
23 | Competition from substitute products |
24 | Gross margin and average profitability of suppliers |
25 | New product development in past 12 months |
26 | M&A in past 12 months |
27 | Growth strategy of leading players |
28 | Market share of vendors, 2023 |
29 | Company Profiles |
30 | Unmet needs and opportunity for new suppliers |
31 | Conclusion |
32 | Appendix |